Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × guadecitabine × Clear all

NCT01752933 2024-08-27

SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC)

Phase 2 Completed

52 enrolled 14 charts

Gastrointestinal

Carcinoma, Hepatocellular